Day: 12 October 2026

BIG 2026 by bpifrance

[#BIG2026] Can an innovation be excellent… without ever being ordered?

A key paradox emerged from the #conversation we moderated yesterday at #BIG, centered on a simple question: how do we create viable demand to accelerate #deeptech in healthcare?

Because there is a long journey between a relevant, available solution and that first order:
→ a value proposition to build for all stakeholders
→ a healthcare facility that must mobilize time, teams, and a budget to run a pilot
→ a procurement process to understand, anticipate, and coordinate
→ a contractual framework that needs to be in place
→ a manufacturer that is still in business to issue the invoice!

Ultimately, it requires orchestrating #alignment among the decision-maker, the payer, the prescriber, the beneficiary, and the end-user…

Market access is an integral part of the investment narrative (equity story) and cannot be considered only after commercial authorizations are granted. Evidence, the decision-making process, the budget, and the procurement pathway must all be prepared together, as early as possible.

Thanks to Noa Bach (AP-HP, Assistance Publique – Hôpitaux de Paris), Peggy Rematier (Bpifrance), Julie Rachline (LallianSe – Catalyseur d’action(s) & ex #Braintale wearing two hats) Louis Potel (Resah) and Hicham CHEHADE (OPTACARE) for their highly complementary insights and experiences… and, of course, to the audience for actively participating in the Q&A and voting throughout the discussion !

A topic that clearly deserves further exploration: how can we shorten the time between an innovation becoming available and its actual use?

#Healthcare#Innovation#bpifrance#modération#dialogue

Julie RachlineShahrzad MoradiMaryline BROWNE-DIGUERHERDavid MarquesOlivier ChabanonLa French CareBpifrance

WMAA by Inspirit Partners

Healthcare in Europe: opportunities for M&A?

This was one of the key questions at the heart of the dialogue held last Friday for the World M&A Alliance, organized by Inspirit Partners. It was a discussion orchestrated and moderated by Julie Rachline, featuring insights from:

Grégoire Chauvière Le Drian – European Investment Bank (EIB)
Loïc Gonnet – Head of M&A at Sanofi,
Benoit Varichon – partner at ARCHIMED
Pascal Raidron – founder of EIGHT ADVISORY

Beyond the specific challenges and diverse realities of the healthcare sector, M&A activity in this field is particularly dynamic and efficient, yet grounded in practical realities: a deal requires foresight and is built on human relationships and a nuanced, local understanding—on both the buyer and seller sides. Culture and local dynamics are crucial; in healthcare, transactions cannot be conceived in isolation from their ecosystem.

It is precisely at the intersection of these factors that LallianSe supports and connects players in the sector.

Julie Rachline Shahrzad Moradi Maryline BROWNE-DIGUERHER Thierry Hassanaly Nicolas JULLIAN

GHU Sorbonne University

Do you speak « LallianSe » ?

A doctor doesn’t speak the same language as an entrepreneur. An entrepreneur doesn’t speak the same language as hospital management. Hospital management doesn’t speak the same language as an investor. An investor doesn’t speak the same language… you get the idea—it’s an endless loop!

And yet… talking, dialogue, and collaboration are essential for a healthcare innovation to become a reality. That is precisely where our story with the AP-HP (Assistance Publique – Hôpitaux de Paris) began in 2017, when we set up operations at the heart of the Pitié-Salpêtrière – Charles Foix University Hospitals. Over seven years of #hospitalimmersion, we gradually learned the codes, constraints, and realities—and learned to speak the languages—of the hospital ecosystem. Above all, we sparked #conversations.

These conversations paved the way for concrete initiatives: from the creation of #ASIIA (the Association of Innovative Start-ups from AP-HP) and the #BrainTale project to supporting the #OBE Foundation, as well as numerous collaborations involving doctors, paramedical staff, entrepreneurs, and other ecosystem stakeholders.

This spirit was very much present at the event “From Hospital to Start-up: Entrepreneurship for Healthcare Innovation,” held at the Sorbonne University Hospital Group (GHU). Four clinician-entrepreneurs came to share what drove them to take the leap into entrepreneurship: Pierre Mozer, Rachel Lévy, Harry Sokol, Louis PUYBASSET.

It was about translating the challenges of one “world” to make them understandable to another; enabling a clinician, an entrepreneur, an institution, or an investor to understand one another well enough to build together.

This ability to build bridges is what we have been cultivating for over a decade: creating the conditions for worlds that do not naturally speak the same language to understand each other, collaborate, and bring projects to life.

#HealthInnovation #Entrepreneurship #APHP #RoundTable #Startup